These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9042306)

  • 1. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
    Weber G; Nagai M; Natsumeda Y; Eble JN; Jayaram HN; Paulik E; Zhen WN; Hoffman R; Tricot G
    Cancer Commun; 1991 Mar; 3(3):61-6. PubMed ID: 1705812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased signal transduction activity and down-regulation in human cancer cells.
    Weber G; Shen F; Prajda N; Yeh YA; Yang H; Herenyiova M; Look KY
    Anticancer Res; 1996; 16(6A):3271-82. PubMed ID: 9042300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
    Vitale M; Zamai L; Falcieri E; Zauli G; Gobbi P; Santi S; Cinti C; Weber G
    Cytometry; 1997 Feb; 30(1):61-6. PubMed ID: 9056744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiazofurin decreases Ras-GTP complex in K562 cells.
    Hata Y; Natsumeda Y; Weber G
    Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical issues in chemotherapy with tiazofurin.
    Weber G
    Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis.
    Wright DG; Boosalis MS; Waraska K; Oshry LJ; Weintraub LR; Vosburgh E
    Anticancer Res; 1996; 16(6A):3349-51. PubMed ID: 9042310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
    Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
    Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E
    Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the signal transduction program by drugs.
    Weber G; Shen F; Prajda N; Yang H; Li W; Yeh A; Csokay B; Olah E; Look KY
    Adv Enzyme Regul; 1997; 37():35-55. PubMed ID: 9381980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
    Look KY; Sutton GP; Natsumeda Y; Eble JN; Stehman FB; Ehrlich CE; Olah E; Prajda N; Bosze P; Eckhardt S
    Gynecol Oncol; 1992 Oct; 47(1):66-70. PubMed ID: 1358769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
    Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of de novo and salvage pathways in chemotherapy.
    Weber G; Nagai M; Natsumeda Y; Ichikawa S; Nakamura H; Eble JN; Jayaram HN; Zhen WN; Paulik E; Hoffman R
    Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.